Function Therapeutics LLC, based in Milwaukee, WI, is a pioneering biopharmaceutical company focused on developing a new class of anti-inflammatory drugs known as Parmodulins. These small molecules selectively target Protease-Activated Receptor signaling to modulate inflammatory responses, with a particular emphasis on treating inflammation-driven diseases like chronic kidney disease.
Founded by Dr. Chris Dockendorff and supported by a seasoned team with expertise in medicinal chemistry and PAR biology, Function Therapeutics is translating innovative research into novel therapeutics to combat inflammatory disorders. With a strong track record of scientific advancements and recent accolades, the company is at the forefront of developing promising treatments for conditions such as sepsis and acute kidney injury.
Generated from the website